Pregnancy complications may signal later heart and kidney disease risk, study of 1.4 million women finds

A sweeping analysis of more than 1.4 million pregnant women in England has revealed that complications during pregnancy, whether in the most recent pregnancy or in earlier ones, are associated with a substantially elevated risk of developing serious cardiometabolic-renal conditions in the years that follow. The study, published online in the open access journal BMJ Medicine, suggests that a woman’s complete reproductive history could serve as a powerful and underused window into her future cardiovascular, metabolic, and kidney health, and that the postpartum period may represent a critical, yet frequently missed, opportunity for prevention.

The research team, drawing on a large primary care database of women registered with a general practitioner in the UK between 1 January 2000 and 31 December 2022, linked primary care records with hospital data to identify pregnancy complications across the full reproductive lifespan. This longitudinal design allowed the investigators to follow women for an average of four years after pregnancy, tracking the emergence of four key outcomes: cardiovascular disease, type 2 diabetes, high blood pressure, and chronic kidney disease. By capturing complications from all previous pregnancies rather than only the most recent one, the study addresses a significant blind spot in the existing literature.

The scale of the associations uncovered is striking. Gestational hypertension and pre-eclampsia, two of the best-known hypertensive disorders of pregnancy, more than tripled the rate of hypertension in later life and approximately doubled the rate of chronic kidney disease, with smaller but still meaningful increases in cardiovascular disease and type 2 diabetes. Gestational diabetes, a form of glucose intolerance first recognised during pregnancy, was associated with a sevenfold higher rate of type 2 diabetes in subsequent years, alongside increased rates of hypertension and cardiovascular disease. These figures underscore the physiological burden that abnormal pregnancies may impose on maternal organ systems.

Beyond these established links, the study also illuminated associations that had previously been supported only by limited evidence. Postnatal depression following the most recent pregnancy was found to increase the rate of all four cardiometabolic-renal outcomes by between 35 and 56 percent, a finding that places mental health squarely within the conversation about long-term physical health after childbirth. Miscarriage, stillbirth, placental abruption, in which the placenta separates from the inner wall of the womb before delivery, preterm birth, and the delivery of babies who are either small or large for their gestational age were each associated with modestly higher rates of one or more of the four outcomes studied.

The biological rationale for these connections is an area of active investigation. Pregnancy places considerable demands on the maternal cardiovascular system, with blood volume expanding dramatically and the kidneys filtering at heightened capacity for months. Hypertensive disorders of pregnancy are thought to reveal, or possibly contribute to, an underlying predisposition to vascular dysfunction, while gestational diabetes may unmask latent impairments in glucose metabolism that would otherwise remain silent for years. The authors of the new study are careful to emphasise that more research is needed to better understand the underlying mechanisms behind these associations and to determine whether incorporating pregnancy history into existing risk models genuinely improves the prediction of future heart, kidney, and metabolic disease.

Importantly, the researchers stress that this is an observational study, and its design cannot establish that pregnancy complications cause the later diseases. Instead, the authors suggest that a complication functions as a clinical marker of underlying risk, a signal that a woman’s physiology has already begun to deviate from a healthy trajectory. In this framing, gestational diabetes, pre-eclampsia, and related conditions act less like independent culprits and more like early warning lights on a dashboard, alerting clinicians that closer surveillance and earlier intervention may be warranted long before symptoms of cardiovascular or renal disease appear.

The methodological strengths of the analysis lend considerable weight to its findings. The use of a large general practice database that reflects the UK population in terms of geography, deprivation, and age reduces the risk that the results are an artefact of a narrow or unrepresentative sample. Linking primary care records to hospital data provided a more complete picture of pregnancy complications than either source alone could offer. Nevertheless, the authors acknowledge limitations, including the absence of data on dietary habits and physical activity, both of which influence cardiometabolic risk, and the fact that ethnicity data was missing for around a fifth of the study group, a gap that matters given known disparities in pregnancy outcomes and cardiovascular disease across ethnic groups.

The practical implications of the research could be far-reaching. The authors conclude that several pregnancy complications, including those occurring in previous pregnancies, were associated with an increased risk of cardiometabolic-renal conditions in the years after pregnancy. They add that these findings support obtaining a full reproductive history and using the postpartum period as an opportune time for risk assessment and preventative cardioprotective strategies in women with a history of adverse pregnancy outcomes. In other words, a routine question about past miscarriages, hypertensive pregnancies, or episodes of gestational diabetes could meaningfully reshape how clinicians stratify risk and tailor prevention for millions of women.

For women themselves, the message is not one of alarm but of empowerment through information. Many people who experience a difficult pregnancy move on without ever realising that the event may carry implications for their health decades later. If pregnancy complications are recognised as legitimate entries on a lifelong risk profile, women with such histories could be offered earlier blood pressure monitoring, glucose screening, and kidney function testing, along with lifestyle and, where appropriate, pharmacological interventions proven to reduce cardiovascular risk. The study’s authors and the journal’s editors alike suggest that the postpartum window, when women are already in regular contact with health services, is a natural moment to begin this conversation.

As cardiometabolic disease remains a leading cause of death and disability among women worldwide, the finding that pregnancy acts as a natural stress test for the heart, kidneys, and metabolism offers a compelling reframing of antenatal care. What has long been treated as a discrete chapter ending at delivery may instead be the first chapter of a much longer health story, one that clinicians, researchers, and patients are only now learning to read. The challenge ahead lies in translating these population-level associations into clinical practice, refining risk models that incorporate reproductive history, and ensuring that the women flagged by this research receive the follow-up care that could alter their long-term trajectories.

Subject of Research: Association between pregnancy complications and long-term cardiometabolic-renal disease risk in women

Article Title: Pregnancy complications linked to higher risk of cardiac and renal health conditions

Article References: Pregnancy complications linked to higher risk of cardiac and renal health conditions. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: pregnancy complications, gestational diabetes, pre-eclampsia, cardiovascular disease, type 2 diabetes, chronic kidney disease, hypertension, postnatal depression, miscarriage, preterm birth, BMJ Medicine, observational study